FindTrial
Sign In

Serum fructosamine levels in mothers with gestational diabetes and its ability to predict complications in their newborn babies

Association between serum fructosamine levels and neonatal outcomes in a prospective cohort of women with gestational diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063188
Enrollment
310
Registered
2024-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O244- Gestational diabetes mellitus

Interventions

Intervention1: NIL: NIL SINCE IT IS AN OBSERVATIONAL STUDY

Sponsors

DR. SHALINI NAIR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with Gestational Diabetes Mellitus Singleton pregnancies At 36-38 weeks of gestation

Exclusion criteria

Exclusion criteria: Multiple gestation Thyroid dysfunction Steroid use Nephrotic syndrome Known cases of overt diabetes mellitus (type 1, type 2)

Design outcomes

Primary

MeasureTime frame
Correlation between serum fructosamine levels and neonatal outcomes in women with gestational diabetesTimepoint: at 36-38 weeks of gestation—

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE—

Countries

India

Contacts

Public ContactDr Rajani Upadhyaya

Kasturba Medical College and Hospital, Manipal, Karnataka

drram.nambiar@manipal.edu9845082923

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026